POSCO BioVentures&s; primary investment focus is on companies with novel, proprietary bio-molecules.
Business Model:
Revenue: $9.8M
Employees: 11-50
Address: 2121 Palomar Airport Rd
City: Carlsbad
State: CA
Zip: 92011
Country: US
POSCO BioVentures&s; primary investment focus is on companies with novel, proprietary bio-molecules. POSCO BioVentures expects that 70% of its investments will be in companies focused on novel proprietary bio-molecules, with the balance of the investments in other enabling technologies.
Contact Phone:
+17604482848
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2004 | TransMedics | Series B | 27.6M |
3/2004 | TransMolecular | Series C | 0 |
1/2011 | Accera | Series D | 0 |
8/2002 | Archemix | Series A | 51.8M |
11/2008 | Accera | Series C | 0 |
12/2003 | Emergent Respiratory | Venture Round | 5.3M |
3/2006 | TransMedics | Series C | 0 |
4/2004 | Archemix | Series B | 50M |
1/2006 | ProteinSimple | Series B | 0 |
1/2004 | PTC Therapeutics | Series E | 35M |
6/2004 | Nucleonics | Series B | 49.2M |
6/2004 | PTC Therapeutics | Series E | 0 |
4/2007 | TransMedics | Series D | 0 |
1/2005 | GeneOhm Sciences | Series C | 0 |
3/2010 | TransMedics | Series E | 0 |
3/2010 | Pulmonx | Series C | 0 |
9/2004 | Accera | Series A | 0 |
1/2011 | Accera | Series D | 0 |
3/2010 | TransMedics | Series E | 0 |
3/2010 | Pulmonx | Series C | 0 |
11/2008 | Accera | Series C | 0 |
4/2007 | TransMedics | Series D | 0 |
3/2006 | TransMedics | Series C | 0 |
1/2006 | ProteinSimple | Series B | 0 |
1/2005 | GeneOhm Sciences | Series C | 0 |
9/2004 | Accera | Series A | 0 |
6/2004 | PTC Therapeutics | Series E | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|